At On Options we're always looking out for special opportunities we believe you, as a valued reader, will want to see. Below is a message from our colleagues that we think you should check out.
The results come two weeks after Pfizer slashed its full-year adjusted earnings and revenue guidance and launched a sweeping $3.5 billion cost-cutting plan. (Read More)
Tidak ada komentar:
Posting Komentar